MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-05-0056515
Kumra Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹16.73 Lakh
▲ 321% YoY
Net profit · FY 2024
₹2.65 Lakh
Net margin 15.9%
EBITDA · FY 2024
₹3.61 Lakh
EBITDA margin 21.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹52 Lakh
Issued & subscribed
Company age
31 yrs
Est. 1995
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Kumra Pharma Private Limited
Data last updated:
Kumra Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 December 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC074702. Its GSTIN is 07AAACK3021C1ZB (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹52 Lakh. It is led by directors including Monika Kumra and Atul Kumra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 105 Padma Tower – II 22 Rajendra Place, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.73 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.65 Lakh (net margin 15.9%) and EBITDA of ₹3.61 Lakh (EBITDA margin 21.6%). Revenue has grown at a compounded annual rate (CAGR) of 425% over three years.
The company is associated with 1 brand: Kumra Pharma. Court records list 2 cases involving the company, including 2 filed against it.
Kumra Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0056515). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kumrapharma.com.
Company details
CIN U74899DL1995PTC074702
Registration Number 074702
Incorporation Date 18 December 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0056515
Recognitions & Rankings of Kumra Pharma
Contact details
Kumra Pharma Private Limited's registered office is in Delhi, Delhi. Its website is kumrapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address105 Padma Tower – II 22 Rajendra Place, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kumra Pharma Private Limited, buy the company report.
Comprehensive company report
Kumra Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kumra Pharma operates one associated brand: Kumra Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces safe and affordable medicines with research, manufacturing, and distribution services. | kumrapharma.com |
Business activity
The main business activity of Kumra Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Kumra Pharma Private Limited, buy the company report.
Financials of Kumra Pharma Private Limited
FY 2025 filings availableKumra Pharma Private Limited reported revenue of ₹16.73 Lakh (up 321% YoY) for FY 2024.
Revenue · FY 2024
₹16.73 Lakh ▲ 321%
Net profit · FY 2024
₹2.65 Lakh margin 15.9%
EBITDA · FY 2024
₹3.61 Lakh margin 21.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 321%
3 years · compounded
▲ 425%
EBITDA CAGR growth
1 year
▲ 466%
3 years · compounded
▲ 69%
5 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 425% over three years, including 321% growth in the latest year. EBITDA rose 466% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.6% | ||||
| Net Profit Margin | 15.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kumra Pharma Private Limited, buy the company report.
Board of directors of Kumra Pharma Private Limited
Kumra Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monika Kumra Also directs: Medicine House Global LLP, Nutralabs LLP, Karmed Lifesciences Private Limited and 1 more | Director | 18 Dec 1995 | 30 Years 10 Months | Current |
| Atul Kumra | Director | 18 Dec 1995 | 30 Years 10 Months | Current |
| Arjun Kumra | Director | 28 Nov 2016 | 9 Years 10 Months | Current |
Auditor
Kumra Pharma Private Limited is audited by P KUMAR JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P KUMAR JAIN & CO. | FY 2023 | 003817N |
Shareholding
The shareholding of Kumra Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kumra Pharma Private Limited, buy the company report.
Legal cases
Kumra Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
To see the full case history of Kumra Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kumra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kumra Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACK3021C1ZB | Delhi | Active | 19 Aug 2020 |
To see the full GST registrations and return filing status of Kumra Pharma Private Limited, buy the company report.
Recent activity
Kumra Pharma Private Limited has 4 board changes on record since 1995: 3 appointments and 1 cessation. The latest: Arjun Kumra was appointed as Director on 28 Nov 2016.
AGM
Kumra Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kumra Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Arjun Kumra was appointed as Director.
Ceased
Surendera Kumar Kumra ceased to be Director.
Appointed
Atul Kumra was appointed as Director.
Appointed
Monika Kumra was appointed as Director.
Incorporation
18 Dec 1995
Kumra Pharma Private Limited was registered on 18 Dec 1995 with Roc Delhi & aged 30 years 10 months as per MCA records.
Frequently asked questions
Kumra Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 December 1995 (31+ years old) and is registered under CIN U74899DL1995PTC074702.
Kumra Pharma has 3 current directors:
- Monika Kumra - Director
- Atul Kumra - Director
- Arjun Kumra - Director
The latest financial statements of Kumra Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kumra Pharma is 07AAACK3021C1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Kumra Pharma is U74899DL1995PTC074702. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kumra Pharma has 2 court cases on record: 2 filed against it.
Kumra Pharma was incorporated on 18 December 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Arjun Kumra was appointed as Director on 28 Nov 2016. Surendera Kumar Kumra ceased to be Director on 12 Mar 2016. Atul Kumra was appointed as Director on 18 Dec 1995. Kumra Pharma has 4 board changes on record in total.
Yes, Kumra Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0056515).
Kumra Pharma can be reached through the website kumrapharma.com. Its registered office is in Delhi, India.